1 Market Overview
1.1 Product Overview and Scope of Human Prothrombin Complex Concentrate
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Prothrombin Complex Concentrate Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 500 IU
1.3.3 1000 IU
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Prothrombin Complex Concentrate Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hemophilia B
1.4.3 Vitamin K Deficiency
1.4.4 Other
1.5 Global Human Prothrombin Complex Concentrate Market Size & Forecast
1.5.1 Global Human Prothrombin Complex Concentrate Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Prothrombin Complex Concentrate Sales Quantity (2018-2029)
1.5.3 Global Human Prothrombin Complex Concentrate Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Octapharma
2.1.1 Octapharma Details
2.1.2 Octapharma Major Business
2.1.3 Octapharma Human Prothrombin Complex Concentrate Product and Services
2.1.4 Octapharma Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Octapharma Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Prothrombin Complex Concentrate Product and Services
2.2.4 CSL Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 Beijing Tiantan Biological Products Co., Ltd.
2.3.1 Beijing Tiantan Biological Products Co., Ltd. Details
2.3.2 Beijing Tiantan Biological Products Co., Ltd. Major Business
2.3.3 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
2.3.4 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments/Updates
2.4 Shanghai RAAS
2.4.1 Shanghai RAAS Details
2.4.2 Shanghai RAAS Major Business
2.4.3 Shanghai RAAS Human Prothrombin Complex Concentrate Product and Services
2.4.4 Shanghai RAAS Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai RAAS Recent Developments/Updates
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Human Prothrombin Complex Concentrate Product and Services
2.5.4 Biotest Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Biotest Recent Developments/Updates
2.6 Thailand Bio
2.6.1 Thailand Bio Details
2.6.2 Thailand Bio Major Business
2.6.3 Thailand Bio Human Prothrombin Complex Concentrate Product and Services
2.6.4 Thailand Bio Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Thailand Bio Recent Developments/Updates
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Human Prothrombin Complex Concentrate Product and Services
2.7.4 Hualan Bio Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hualan Bio Recent Developments/Updates
2.8 Weiguang Biology
2.8.1 Weiguang Biology Details
2.8.2 Weiguang Biology Major Business
2.8.3 Weiguang Biology Human Prothrombin Complex Concentrate Product and Services
2.8.4 Weiguang Biology Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Weiguang Biology Recent Developments/Updates
2.9 Green Cross (China) Biological Products Co., Ltd.
2.9.1 Green Cross (China) Biological Products Co., Ltd. Details
2.9.2 Green Cross (China) Biological Products Co., Ltd. Major Business
2.9.3 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
2.9.4 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Green Cross (China) Biological Products Co., Ltd. Recent Developments/Updates
2.10 Beijing Bohui Innovative Biotechnology Group Co., Ltd.
2.10.1 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Details
2.10.2 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Major Business
2.10.3 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
2.10.4 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments/Updates
2.11 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
2.11.1 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Details
2.11.2 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Major Business
2.11.3 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
2.11.4 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Jiangxi Boya Biopharmaceutical Co., Ltd.
2.12.1 Jiangxi Boya Biopharmaceutical Co., Ltd. Details
2.12.2 Jiangxi Boya Biopharmaceutical Co., Ltd. Major Business
2.12.3 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
2.12.4 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Human Prothrombin Complex Concentrate Product and Services
2.13.4 Takeda Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Takeda Recent Developments/Updates
2.14 Grifols
2.14.1 Grifols Details
2.14.2 Grifols Major Business
2.14.3 Grifols Human Prothrombin Complex Concentrate Product and Services
2.14.4 Grifols Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Grifols Recent Developments/Updates
2.15 Shanghai Emerging Pharmaceuticals
2.15.1 Shanghai Emerging Pharmaceuticals Details
2.15.2 Shanghai Emerging Pharmaceuticals Major Business
2.15.3 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product and Services
2.15.4 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shanghai Emerging Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Human Prothrombin Complex Concentrate by Manufacturer
3.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Prothrombin Complex Concentrate Revenue by Manufacturer (2018-2023)
3.3 Global Human Prothrombin Complex Concentrate Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Prothrombin Complex Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Prothrombin Complex Concentrate Manufacturer Market Share in 2022
3.4.2 Top 6 Human Prothrombin Complex Concentrate Manufacturer Market Share in 2022
3.5 Human Prothrombin Complex Concentrate Market: Overall Company Footprint Analysis
3.5.1 Human Prothrombin Complex Concentrate Market: Region Footprint
3.5.2 Human Prothrombin Complex Concentrate Market: Company Product Type Footprint
3.5.3 Human Prothrombin Complex Concentrate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Prothrombin Complex Concentrate Market Size by Region
4.1.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Region (2018-2029)
4.1.2 Global Human Prothrombin Complex Concentrate Consumption Value by Region (2018-2029)
4.1.3 Global Human Prothrombin Complex Concentrate Average Price by Region (2018-2029)
4.2 North America Human Prothrombin Complex Concentrate Consumption Value (2018-2029)
4.3 Europe Human Prothrombin Complex Concentrate Consumption Value (2018-2029)
4.4 Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value (2018-2029)
4.5 South America Human Prothrombin Complex Concentrate Consumption Value (2018-2029)
4.6 Middle East and Africa Human Prothrombin Complex Concentrate Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2029)
5.2 Global Human Prothrombin Complex Concentrate Consumption Value by Type (2018-2029)
5.3 Global Human Prothrombin Complex Concentrate Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2029)
6.2 Global Human Prothrombin Complex Concentrate Consumption Value by Application (2018-2029)
6.3 Global Human Prothrombin Complex Concentrate Average Price by Application (2018-2029)
7 North America
7.1 North America Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2029)
7.2 North America Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2029)
7.3 North America Human Prothrombin Complex Concentrate Market Size by Country
7.3.1 North America Human Prothrombin Complex Concentrate Sales Quantity by Country (2018-2029)
7.3.2 North America Human Prothrombin Complex Concentrate Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2029)
8.2 Europe Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2029)
8.3 Europe Human Prothrombin Complex Concentrate Market Size by Country
8.3.1 Europe Human Prothrombin Complex Concentrate Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Prothrombin Complex Concentrate Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Prothrombin Complex Concentrate Market Size by Region
9.3.1 Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2029)
10.2 South America Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2029)
10.3 South America Human Prothrombin Complex Concentrate Market Size by Country
10.3.1 South America Human Prothrombin Complex Concentrate Sales Quantity by Country (2018-2029)
10.3.2 South America Human Prothrombin Complex Concentrate Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Prothrombin Complex Concentrate Market Size by Country
11.3.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Prothrombin Complex Concentrate Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Prothrombin Complex Concentrate Market Drivers
12.2 Human Prothrombin Complex Concentrate Market Restraints
12.3 Human Prothrombin Complex Concentrate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Prothrombin Complex Concentrate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Prothrombin Complex Concentrate
13.3 Human Prothrombin Complex Concentrate Production Process
13.4 Human Prothrombin Complex Concentrate Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Prothrombin Complex Concentrate Typical Distributors
14.3 Human Prothrombin Complex Concentrate Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Human Prothrombin Complex Concentrate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Prothrombin Complex Concentrate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Octapharma Basic Information, Manufacturing Base and Competitors
Table 4. Octapharma Major Business
Table 5. Octapharma Human Prothrombin Complex Concentrate Product and Services
Table 6. Octapharma Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Octapharma Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Human Prothrombin Complex Concentrate Product and Services
Table 11. CSL Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. Beijing Tiantan Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Tiantan Biological Products Co., Ltd. Major Business
Table 15. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
Table 16. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beijing Tiantan Biological Products Co., Ltd. Recent Developments/Updates
Table 18. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 19. Shanghai RAAS Major Business
Table 20. Shanghai RAAS Human Prothrombin Complex Concentrate Product and Services
Table 21. Shanghai RAAS Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shanghai RAAS Recent Developments/Updates
Table 23. Biotest Basic Information, Manufacturing Base and Competitors
Table 24. Biotest Major Business
Table 25. Biotest Human Prothrombin Complex Concentrate Product and Services
Table 26. Biotest Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Biotest Recent Developments/Updates
Table 28. Thailand Bio Basic Information, Manufacturing Base and Competitors
Table 29. Thailand Bio Major Business
Table 30. Thailand Bio Human Prothrombin Complex Concentrate Product and Services
Table 31. Thailand Bio Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Thailand Bio Recent Developments/Updates
Table 33. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 34. Hualan Bio Major Business
Table 35. Hualan Bio Human Prothrombin Complex Concentrate Product and Services
Table 36. Hualan Bio Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hualan Bio Recent Developments/Updates
Table 38. Weiguang Biology Basic Information, Manufacturing Base and Competitors
Table 39. Weiguang Biology Major Business
Table 40. Weiguang Biology Human Prothrombin Complex Concentrate Product and Services
Table 41. Weiguang Biology Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Weiguang Biology Recent Developments/Updates
Table 43. Green Cross (China) Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Green Cross (China) Biological Products Co., Ltd. Major Business
Table 45. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
Table 46. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Green Cross (China) Biological Products Co., Ltd. Recent Developments/Updates
Table 48. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Major Business
Table 50. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
Table 51. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments/Updates
Table 53. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Major Business
Table 55. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
Table 56. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Jiangxi Boya Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Jiangxi Boya Biopharmaceutical Co., Ltd. Major Business
Table 60. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product and Services
Table 61. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Takeda Basic Information, Manufacturing Base and Competitors
Table 64. Takeda Major Business
Table 65. Takeda Human Prothrombin Complex Concentrate Product and Services
Table 66. Takeda Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Takeda Recent Developments/Updates
Table 68. Grifols Basic Information, Manufacturing Base and Competitors
Table 69. Grifols Major Business
Table 70. Grifols Human Prothrombin Complex Concentrate Product and Services
Table 71. Grifols Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Grifols Recent Developments/Updates
Table 73. Shanghai Emerging Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Emerging Pharmaceuticals Major Business
Table 75. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product and Services
Table 76. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shanghai Emerging Pharmaceuticals Recent Developments/Updates
Table 78. Global Human Prothrombin Complex Concentrate Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Human Prothrombin Complex Concentrate Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Human Prothrombin Complex Concentrate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Human Prothrombin Complex Concentrate, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Human Prothrombin Complex Concentrate Production Site of Key Manufacturer
Table 83. Human Prothrombin Complex Concentrate Market: Company Product Type Footprint
Table 84. Human Prothrombin Complex Concentrate Market: Company Product Application Footprint
Table 85. Human Prothrombin Complex Concentrate New Market Entrants and Barriers to Market Entry
Table 86. Human Prothrombin Complex Concentrate Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Human Prothrombin Complex Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Human Prothrombin Complex Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Human Prothrombin Complex Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Human Prothrombin Complex Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Human Prothrombin Complex Concentrate Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Human Prothrombin Complex Concentrate Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Human Prothrombin Complex Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Human Prothrombin Complex Concentrate Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Human Prothrombin Complex Concentrate Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Human Prothrombin Complex Concentrate Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Human Prothrombin Complex Concentrate Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Human Prothrombin Complex Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Human Prothrombin Complex Concentrate Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Human Prothrombin Complex Concentrate Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Human Prothrombin Complex Concentrate Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Human Prothrombin Complex Concentrate Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Human Prothrombin Complex Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Human Prothrombin Complex Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Human Prothrombin Complex Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Human Prothrombin Complex Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Human Prothrombin Complex Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Human Prothrombin Complex Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Human Prothrombin Complex Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Human Prothrombin Complex Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Human Prothrombin Complex Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Human Prothrombin Complex Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Human Prothrombin Complex Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Human Prothrombin Complex Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Human Prothrombin Complex Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Human Prothrombin Complex Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Human Prothrombin Complex Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Human Prothrombin Complex Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Human Prothrombin Complex Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Human Prothrombin Complex Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Human Prothrombin Complex Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Human Prothrombin Complex Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Human Prothrombin Complex Concentrate Raw Material
Table 146. Key Manufacturers of Human Prothrombin Complex Concentrate Raw Materials
Table 147. Human Prothrombin Complex Concentrate Typical Distributors
Table 148. Human Prothrombin Complex Concentrate Typical Customers
List of Figures
Figure 1. Human Prothrombin Complex Concentrate Picture
Figure 2. Global Human Prothrombin Complex Concentrate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Prothrombin Complex Concentrate Consumption Value Market Share by Type in 2022
Figure 4. 500 IU Examples
Figure 5. 1000 IU Examples
Figure 6. Global Human Prothrombin Complex Concentrate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Prothrombin Complex Concentrate Consumption Value Market Share by Application in 2022
Figure 8. Hemophilia B Examples
Figure 9. Vitamin K Deficiency Examples
Figure 10. Other Examples
Figure 11. Global Human Prothrombin Complex Concentrate Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Human Prothrombin Complex Concentrate Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Human Prothrombin Complex Concentrate Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Human Prothrombin Complex Concentrate Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Human Prothrombin Complex Concentrate Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Human Prothrombin Complex Concentrate Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Human Prothrombin Complex Concentrate by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Human Prothrombin Complex Concentrate Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Human Prothrombin Complex Concentrate Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Human Prothrombin Complex Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Human Prothrombin Complex Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Human Prothrombin Complex Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Human Prothrombin Complex Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Human Prothrombin Complex Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Human Prothrombin Complex Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Human Prothrombin Complex Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Human Prothrombin Complex Concentrate Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Human Prothrombin Complex Concentrate Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Human Prothrombin Complex Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Human Prothrombin Complex Concentrate Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Human Prothrombin Complex Concentrate Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Human Prothrombin Complex Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Human Prothrombin Complex Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Human Prothrombin Complex Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Human Prothrombin Complex Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Human Prothrombin Complex Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Human Prothrombin Complex Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Human Prothrombin Complex Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Human Prothrombin Complex Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Human Prothrombin Complex Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Human Prothrombin Complex Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 53. China Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Human Prothrombin Complex Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Human Prothrombin Complex Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Human Prothrombin Complex Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Human Prothrombin Complex Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Human Prothrombin Complex Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Human Prothrombin Complex Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Human Prothrombin Complex Concentrate Market Drivers
Figure 74. Human Prothrombin Complex Concentrate Market Restraints
Figure 75. Human Prothrombin Complex Concentrate Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Human Prothrombin Complex Concentrate in 2022
Figure 78. Manufacturing Process Analysis of Human Prothrombin Complex Concentrate
Figure 79. Human Prothrombin Complex Concentrate Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
※参考情報 ヒトプロトロンビン複合体濃縮物(Human Prothrombin Complex Concentrate, PCC)は、血液凝固因子の補充療法として用いられる医薬品の一種です。特に、ビタミンK欠乏症や抗凝固療法を受けている患者において、出血のリスクを管理するために用いられます。本稿では、ヒトプロトロンビン複合体濃縮物の定義、特徴、種類、用途、関連技術について詳述いたします。 ヒトプロトロンビン複合体濃縮物は、主にヒトの血漿から抽出された凝固因子の濃縮物であり、主成分としてプロトロンビンを含む複数の血液凝固因子が含まれています。これには、因子II(プロトロンビン)、因子VII、因子IX、因子Xが含まれ、それらは血液凝固カスケードにおいて重要な役割を果たします。この複合体は、急激な出血を抑制したり、出血傾向を改善したりするための効果を持ちます。 ヒトプロトロンビン複合体濃縮物の特徴としては、その迅速な凝固効果が挙げられます。特に、緊急手術や重大な外傷において、迅速に出血を制御する必要がある場合に効果的です。また、投与後の効果発現が迅速であり、数分以内に血液凝固能の改善が見られることが多いです。さらに、使用することで血液凝固因子のバランスを迅速に回復させることが可能になります。 この医薬品にはいくつかの種類がありますが、一般的には、PCCはビタミンK依存性凝固因子の補充を目的としたものと考えられています。市販されている製剤には、活性化されたプロトロンビン複合体濃縮物(aPCC)や、非活性化型PCCがあります。活性化型PCCは、比率が高い因子VIIaを含有しており、特に出血が起こりやすい患者に対してより効果的とされています。一方、非活性化型PCCは、特にビタミンK欠乏症や抗凝固療法を受けている患者に対して使用されます。 使用用途については、ヒトプロトロンビン複合体濃縮物は様々な状況で用いられます。最も一般的な用途は、ビタミンK欠乏症の患者における出血管理です。これには、肝疾患や長期間の抗凝固療法によってビタミンKの供給が減少した場合が含まれます。また、血友病患者においても、急性出血時の治療オプションとして使用されることがあります。これにより、緊急性の高い状況においても迅速に対応できる利点があります。 関連技術については、ヒトプロトロンビン複合体濃縮物の製造過程や評価方法が注目されます。製造には、主に冷凍血漿からの凝集体除去や、特定の凝固因子を選択的に濃縮する技術が用いられています。これにより、製品の安全性や効果を高めることが可能になります。また、最近の研究では、この複合体の代謝や体内動態についての理解が深まってきており、より効果的な投与スケジュールの確立にも寄与しています。 ヒトプロトロンビン複合体濃縮物は、その有効性と安全性に関する研究が進んでおり、特に新たな用途の開発や、副作用のリスクを低減するためのアプローチが模索されています。例えば、抗凝固薬による出血リスクの管理において、PCCを使った新しい治療法が検討されています。これにより、今後、より多くの患者が恩恵を受けることが期待されています。 ただし、使用に際しては副作用や contraindications (禁忌)が存在するため、注意が必要です。特に、特定の患者群においては使用が推奨されない場合もあるため、医療従事者は患者の病歴をしっかりと把握し、総合的な管理を行うことが重要です。 ヒトプロトロンビン複合体濃縮物は、血液の凝固プロセスにおいて重要な役割を果たし、患者の命を脅かす出血事象に迅速に対処するための有用な選択肢です。臨床現場において適切に用いられることで、治療効果を最大化し、副作用を最小限に抑えることができるため、今後もその重要性は増すことでしょう。医療分野における進展や研究の成果が、さらなる治療の選択肢となることを期待しています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/